“We got off to a smart start to this year with continued momentum across the company, achieving quarterly increases in net sales and business activity for each business segment, as well as significant progress in execution. opportunities for expansion. We were very pleased to announce plans to earn Chi-X Asia-Pacific, allowing us to expand our geographic and asset elegance presence, while helping us further expand the distribution of our product offerings to our global network of clients, ”Edward said. T. Tilly, President, President and CEO of Cboe Global Markets. “We remain confident of our ability to meet our medium-term biological net sales expansion target of four to 6 percent emissions and generate further longer-term biological net sales expansion through our continued investments in market opportunities. exciting, as evidenced by our expansion target for non-transactional recurring revenue. Cboe has a forged foundation and I am confident that we have the equipment and capabilities to generate price-creating expansion while remaining focused on our commitment to create long-term pricing for our consumers and shareholders. “
“We reported a quarter of smart results, profits fell year after year compared to complicated comparisons to last year’s record results. Our strong money flow generation allowed us to roll back nearly $93 million to percentage shareholders through percentage buybacks and dividends in the first quarter,” said Brian N. Schell, executive vice president of Cboe Global Markets, CFO and treasurer. << We continue to balance our long-standing priorities for disciplined capital allocation to grow our business in a responsible manner while maintaining a healthy balance sheet and maintaining monetary flexibility to increase shareholder percentage value. Repayment of capital to percentage shareholders. "